The results of this study demonstrate that the CatBoost model constructed based on clinical, imaging and laboratory test features exhibits certain auxiliary predictive value in the preoperative assessment of primary operable parotid tumor nature, with its overall performance slightly superior to that of traditional clinical evaluation and logistic regression models.
Abstract
Background
AND
Purpose
The accurate preoperative classification of parotid tumors is crucial in selecting the appropriate treatment options. This study aimed to develop a machine learning model based on clinical, imaging, and laboratory test data to efficiently determine the preoperative nature of primary operable parotid tumors.
Methods
A total of 779 patients with primary operable parotid tumors receiving surgical treatment from four independent clinical centers were enrolled. Standardized clinical, laboratory and multi-modality imaging indicators were extracted for model construction. We compared diagnostic performance from experienced clinicians' empirical diagnosis and ten machine learning algorithms via receiver operating characteristic (ROC) analysis on internal training/test cohorts and an independent external validation dataset.
RESULT
In total 779 enrolled subjects, empirical clinical prediction yielded an AUC(Area Under the Receiver Operating Characteristic Curve) of 0.83 (95% CI, 0.79-0.87), while the CatBoost model based on integrated multi-source data achieved an AUC of 0.91 (95% CI, 0.85-0.97). The CatBoost model demonstrated a sensitivity of 76%, specificity of 95%, Youden's index of 0.71, and accuracy of 92% for identifying malignant tumors.
Conclusion
The results of this study demonstrate that the CatBoost model constructed based on clinical, imaging and laboratory test features exhibits certain auxiliary predictive value in the preoperative assessment of primary operable parotid tumor nature, with its overall performance slightly superior to that of traditional clinical evaluation and logistic regression models.
The FS-T2WI radiomics can reliably and non-invasively distinguish between benign and malignant parotid tumors, while the TabResNet framework offers a practical reference for building high-performance radiomics models in clinical practice.
Xu-Ran Mao, Yan-Ting Li, Wei Zhang et al.· Journal of cranio-maxillo-fa...· 0 citations
The clinico-radiological variables analyzed using ML showed a predictive performance similar to that of a radiologist in this setting, and the radiomic and combined models achieved a moderate and heterogeneous performance.
Marta García Cerezo, David López Cornejo, Alba Ortigosa-Palomo et al.· Applied Sciences· 0 citations
In this multicenter study, which included external validation, clinical variables provided most of the predictive value for postoperative residual meningioma, whereas radiomic features provided only limited incremental value when added to the clinical model.
Nafiye Şanlıer, Murat Yuce, Umid Sulaimanov et al.· Neurosurgical Focus· 0 citations
The interpretable MRI-based XGBoost model showed favorable performance for identifying the vascular dissemination phenotype in HCC, with SHAP-based interpretability and exploratory transcriptomic context.
Junhan Pan, Cong Zhang, Yitian Wu et al.· Journal of Hepatocellular Ca...· 0 citations
To explore the value of constructing a radiomics combined model based on preoperative dynamic contrast‐enhanced magnetic resonance imaging (DCE‐MRI) for predicting lymphovascular invasion (LVI) in breast cancer.
Hon-Gen Li, Qing Xiao, Yi-Hui Zeng et al.· Cancer Reports· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.